Allogeneic bone marrow transplantation (BMT) from an HLA-identical sibling donor remains the only curative treatment for patients with chronic myelogenous leukemia (CML).1 Unfortunately, only 15% of ...

Researchers have shown that glioblastoma can take over the skull marrow to dissolve bone and feed its own growth, suggesting ...

The global incidence of basal cell carcinoma is increasing due to prolonged exposure to ultraviolet (UV) radiation, genetic predispositions, and an aging population that is more susceptible to skin ...

At this year's American College of Rheumatology (ACR) annual meeting, researchers highlighted emerging approaches aimed at ...

African Swine Fever Virus, ASFV, Viral Entry, Host Cell Invasion, CD163, Siglec-1, Macropinocytosis, Endosomal Escape, Immune Evasion, Signaling Pathways Share and Cite: Marcelino, K.B. and Fang, G.J.

A virus carried by 95% of adults from childhood may trigger bladder cancer decades later by damaging cells during immune ...

Respiratory viruses that have diverse strains and mutate rapidly, such as influenza and COVID-19, are difficult to block ...

(CSE: BIOV) (OTCQB: BVAXF) are trading higher Wednesday after the company reported positive Phase 1 clinical results for its investigational immunotherapy maveropepimut S, or MVP S, in women with ...

Scientists have uncovered a powerful new antibody that disrupts a key protein helping triple-negative breast cancer survive and evade immunity. Triple-negative breast cancer (TNBC) is considered one ...

Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes ...

A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface malignancies in a small case series. Ocular surface malignancies are typically ...

Detailed price information for Biovaxys Technology Corp (BIOV-CN) from The Globe and Mail including charting and trades.